First, type 2 diabetes is a heterogeneous disease in both pathogenesis and clinical manifestation (Inzucchi et al., 2012), thus a high HbA1c at baseline and at follow-up could be due to decreased insulin sensitivity, secretion and β-cell dysfunction (Heianza et al., 2012). This evidence concerns the gene INS and type 2 diabetes mellitus.